Search the Newsreel

BTIG Research Boosts Genius Sports (NYSE:GENI) Price Target to $10.00

BTIG Research has increased its price target for Genius Sports (NYSE:GENI) to $10.00 from $9.00, maintaining a "buy" rating and suggesting a 26.41% upside. This comes amidst broadly positive analyst sentiment, with an average price target of $11.19. Despite reporting strong quarterly revenue growth …

Ternium SA Stock (TX) Closed Down by 3.09% on Aug 6: Key Drivers Unveiled

Ternium SA (TX) stock closed down 3.09% on August 6 due to margin compression from high input costs, global steel oversupply, and a slowdown in Mexican industrial production. Currency volatility in the Southern Cone and the breach of key technical support levels also contributed …

Definium Therapeutics (NASDAQ: DFTX) grows cash to $1.1B, Q2 loss deepens

Definium Therapeutics reported its Q2 2026 financial results, showing a deepened net loss of $159.0 million, primarily due to an $86.2 million non-cash increase in warrant liabilities. Despite the loss, the company significantly increased its cash and investments to $1.1 billion, fueled by an …

Ternium (TX) Is Up 11.8% After Q2 Beat And Margin Jump Is The Bull Case Changed?

Ternium (TX) reported strong second-quarter 2026 results with sales of US$4,340.29 million and net income of US$343.67 million, exceeding expectations. The company's adjusted EBITDA surged by 50% sequentially, and margins improved to 16.5% due to higher shipments and trade defense measures. While these results …

Definium Therapeutics Doles Out Inducement Options to New Staff Ahead of Q2 Report

Definium Therapeutics has granted stock options to six new non-executive employees, allowing them to purchase 115,600 common shares with a four-year vesting period. This move, made under its 2026 Inducement Plan, aims to attract talent as the company advances its late-stage psychedelic-based therapies. The …

Fresenius Medical Care Launches 4008A™Dialysis Machine in China

Fresenius Medical Care has launched its 4008A™ dialysis machine in China, aiming to provide high-quality, cost-effective dialysis treatment to more patients suffering from end-stage renal disease (ESRD). The machine, a collaboration between their Chinese and German R&D teams, is designed to enhance accessibility and …

Definium Therapeutics Q2 Loss Widens

Definium Therapeutics Inc. (DFTX) reported a wider loss in Q2 2026, posting an EPS of -$1.44, which was significantly below FactSet's estimate of -$0.54. The company, formerly Mind Medicine (MindMed) Inc., is focused on developing therapeutics for psychiatric and neurological disorders and is advancing …

Genius Sports Q2 2026 slides: revenue beats guidance, margins expand

Genius Sports (NYSE:GENI) exceeded its Q2 2026 financial guidance, reporting revenue of $196 million and adjusted EBITDA of $53 million, driven by strong growth in betting and media revenue, particularly benefiting from the Legend acquisition. The company raised its full-year 2026 outlook across all …

Fresenius Medical Care (FMC) St-Aktie: DZ BANK vergibt Bewertung mit Kaufen

DZ BANK gibt Fresenius Medical Care (FMC) St-Aktie Kaufen

Earnings Flash (GENI) Genius Sports Posts Q2 Loss $0.28 a Share, vs. FactSet Est of $0.11 Loss

Genius Sports (GENI) reported a Q2 loss of $0.28 per share, which is significantly wider than FactSet's estimated loss of $0.11 per share. Despite the Q2 loss, the company has raised its earnings guidance for the full year 2026 and provided earnings guidance for …

Genius Sports Beats Second Quarter Guidance and Raises Full-Year Outlook

Genius Sports Limited announced strong financial results for its fiscal second quarter ended June 30, 2026, surpassing revenue

Press Metal Aluminium Holdings Berhad Financial Disclosures & Filings

GENIUS SPORTS LIMITED ($GENI) Releases Q2 2026 Earnings

Genius Sports Ltd. (GENI) PT Raised to $12 at Guggenheim

Guggenheim analyst Curry Baker has increased the price target for Genius Sports Ltd. (GENI) to $12. The article provides this update but requires a premium subscription to access further details regarding the analysis and rationale behind the revised price target.

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Receives Average Rating of "Reduce" from Brokerages

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) has received an average rating of "Reduce" from eleven brokerage firms, with five recommending a sell and six a hold. The average 12-month price target is $22.45, below its opening price of $23.91. Despite the "Reduce" …

Elevate Uranium (ASX:EL8): Uranium Exploration Story in Focus After Latest Decline

Ternium Q2 Earnings Call Focuses on Mexico Recovery and Q3 Growth

Manaksia Aluminium Company Share Price: Price Rise Analysis

Uranium Royalty Corp (UROY) Earnings Forecast: Future EPS & Revenue Growth Estimates

Genius Sports Limited (GENI) Reports Q2 Loss, Tops Revenue Estimates

Fresenius Medical Care accelerates income growth to 23% in the second quarter of 2026 while advancing its strategic agenda

Organic revenue growth1 of 5% with growth in all operating segments Operating income2 grew by 23%, resulting in further margin expansion to 11.7% Reported operating income grew by 10% and reported net income3 decreased by 3% Earnings per share2 (EPS) increased by 28%, supported …

A Look at Ternium SA (TX) After 6.7% Gain -- GF Value $37.05 vs Price $53.71

Ternium SA (TX) shares recently rose 6.7% to $53.71, yet GuruFocus assesses the stock as significantly overvalued by 45.0% compared to its GF Value of $37.05. Despite a strong GF Score of 83/100, driven by profitability and momentum, the valuation and growth scores are …

Earnings call transcript: Ternium posts Q2 2026 profit beat as shares rise

Uranium Royalty Corp (59U.HM) analyst ratings, estimates and forecasts

This article provides analyst ratings, estimates, and forecasts for Uranium Royalty Corp (59U.HM). It shows the stock's current price and notes that growth estimates for the current and next quarters, as well as the current and next year, are unavailable for both 59U.HM and …

Uranium Royalty (Nasdaq:UROY) - Stock Analysis

This article provides a detailed stock analysis of Uranium Royalty Corp. (Nasdaq:UROY), covering its financials, performance, and recent news. It highlights the company's shift to profitability in FY 2026, driven by increased revenue, and details its acquisition of a 92% stake in Sweetwater Royalties …

Ternium (NYSE: TX) boosts H1 profit, expands Usiminas stake and details Brazil suit risk

Ternium S.A. reported significantly increased profits for the first half of 2026, with net sales reaching $8.27 billion and profit more than doubling to $836.9 million. The company expanded its economic exposure in Brazil by acquiring an additional stake in Usiminas for $315.2 million, …

Ternium SA Stock (TX) Moved Up by 6.48% on Aug 5: What Signal Does It Send?

Ternium SA (TX) stock surged by 6.48% on August 5th after the company released strong quarterly financial results that surpassed consensus estimates, driven by robust EBITDA margins and resilient shipment volumes, especially from its Mexican operations. Investors are also responding positively to updates on …

Fresenius SE & Co KGaA (FSNUY) (Q2 2026) Earnings Call Highlights: Raises Full-Year EPS ...

This article first appeared on GuruFocus. Release Date: August 05, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Fresenius SE & Co. KGaA (FSNUY) raised its full-year core EPS growth guidance to 10%-15% …

Ternium SA (TX) (Q2 2026) Earnings Call Highlights: Adjusted EBITDA Surges 50% Sequentially, ...

This article first appeared on GuruFocus. Adjusted EBITDA: 50% higher sequentially in Q2 2026. Adjusted EBITDA Margin: Expanded to 16.5% in Q2 2026, up from 12.2% in Q1 2026. Net Income: Reached $465 million in Q2 2026. Net Debt: $112 million at the end …

Jefferies Remains a Sell on Fresenius Medical Care AG & Co. KGaA (0H9X)

Jefferies analyst James Vane maintained a Sell rating on Fresenius Medical Care AG & Co. KGaA (0H9X) with a price target of €31.00. This follows similar Sell ratings from UBS and a Hold rating from Bernstein on the same day. The article notes the …

Genius Sports earnings on deck: Can Legend deal deliver?

Genius Sports is poised to report second-quarter results, with investors keenly focused on the integration of its $1.2 billion Legend acquisition and its impact on the company's business model and narrowing losses. Analysts anticipate a loss of 8 cents per share on $184.8 million …

FMS Q2 Earnings Rise on Care Delivery, Revenues Miss, Margins Expand

Fresenius Medical Care AG FMS reported second-quarter 2026 adjusted earnings per share (EPS) of 66 cents, which increased 28% year over year at constant currency (cc), supported by stronger Care Delivery profitability and share repurchases. FMS Posts Solid Organic Revenue Growth Revenues rose 0.9% …

Ternium (NYSE:TX) Hits New 1-Year High After Strong Earnings

Ternium (NYSE:TX) shares have reached a new 52-week high of $52.71 after the company reported strong quarterly earnings, including $1.80 EPS and $4.34 billion in revenue. Analyst sentiment remains largely positive with a "Moderate Buy" consensus and an average price target of $47.94, despite …

Uranium Royalty (NASDAQ:UROY) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Uranium Royalty Corp. (NASDAQ:UROY) reported robust earnings, but an analysis reveals some underlying concerns for shareholders. The company's accrual ratio of -1.06 indicates strong free cash flow generation relative to statutory profit, with FCF at US$178m against US$40.2m profit. However, significant share dilution (185% …

Genius Sports and Kalshi strike major official data, media and integrity partnership

Genius Sports has partnered with Kalshi, a leading prediction market, to provide official data, marketing, media